Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0MT8G
|
|||
Drug Name |
FKB01MD
|
|||
Company |
Fabre-Kramer Pharmaceuticals Houston, TX
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 1A receptor (HTR1A) | Target Info | Modulator | [1] |
5-HT 1D receptor (HTR1D) | Target Info | Agonist | [1] | |
5-HT 2 receptor (5HT2R) | Target Info | Inhibitor | [1] | |
KEGG Pathway | cAMP signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Serotonergic synapse | ||||
Calcium signaling pathway | ||||
Gap junction | ||||
Inflammatory mediator regulation of TRP channels | ||||
Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
5HT1 type receptor mediated signaling pathway | ||||
Reactome | Serotonin receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Serotonin HTR1 Group and FOS Pathway | |||
Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
SIDS Susceptibility Pathways |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.